These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26460553)

  • 1. Sensory modulation intervention and behaviour support modification for the treatment of severe aggression in Huntington's disease. A single case experimental design.
    Fisher CA; Brown A
    Neuropsychol Rehabil; 2017 Sep; 27(6):891-903. PubMed ID: 26460553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of aggression in Huntington's disease: rates, types and antecedents in an inpatient rehabilitation setting.
    Brown A; Sewell K; Fisher CA
    J Clin Nurs; 2017 Oct; 26(19-20):2922-2931. PubMed ID: 27731917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods.
    Fisher CA; Sewell K; Brown A; Churchyard A
    J Huntingtons Dis; 2014; 3(4):319-32. PubMed ID: 25575953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Music therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial.
    van Bruggen-Rufi M; Vink A; Achterberg W; Roos R
    BMC Psychol; 2016 Jul; 4(1):38. PubMed ID: 27457568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social Behaviour is Impaired in the R6/2 Mouse Model of Huntington’s Disease.
    Wood NI; Morton AJ
    J Huntingtons Dis; 2015; 4(1):61-73. PubMed ID: 26333258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural relaxation training with Huntington's disease patients: a pilot study.
    Fecteau GW; Boyne J
    Psychol Rep; 1987 Aug; 61(1):151-7. PubMed ID: 2959978
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using single-case experimental design methodology to evaluate the effects of the ABC method for nursing staff on verbal aggressive behaviour after acquired brain injury.
    Winkens I; Ponds R; Pouwels C; Eilander H; van Heugten C
    Neuropsychol Rehabil; 2014; 24(3-4):349-64. PubMed ID: 24766443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive behavior in Huntington's disease: treatment with propranolol.
    Stewart JT; Mounts ML; Clark RL
    J Clin Psychiatry; 1987 Mar; 48(3):106-8. PubMed ID: 2880838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in mental state and behaviour in Huntington's disease.
    Eddy CM; Parkinson EG; Rickards HE
    Lancet Psychiatry; 2016 Nov; 3(11):1079-1086. PubMed ID: 27663851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Huntington Study Group Reach2HD Investigators
    Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial.
    van Bruggen-Rufi MC; Vink AC; Wolterbeek R; Achterberg WP; Roos RA
    J Huntingtons Dis; 2017; 6(1):63-72. PubMed ID: 28304313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena.
    Naarding P; Kremer HP; Zitman FG
    Eur Psychiatry; 2001 Dec; 16(8):439-45. PubMed ID: 11777733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse behavioral effects of amantadine therapy in Huntington's disease.
    Stewart JT
    South Med J; 1987 Oct; 80(10):1324-5. PubMed ID: 2958943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study.
    van Walsem MR; Howe EI; Iversen K; Frich JC; Andelic N
    Orphanet J Rare Dis; 2015 Sep; 10():124. PubMed ID: 26411462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical response to pindolol treatment for aggression in a patient with Huntington's disease.
    von Hafften AH; Jensen CF
    J Clin Psychiatry; 1989 Jun; 50(6):230-1. PubMed ID: 2524472
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of zuclopenthixol in the treatment of aggression in Huntington's disease.
    Tibrewal P; Bastiampillai T; Dhillon R; Cheng R; Fonseka HT
    Asian J Psychiatr; 2017 Apr; 26():152-153. PubMed ID: 28483083
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive interventions to enhance neural compensation in Huntington's disease.
    Andrews SC; Domínguez JF; Mercieca EC; Georgiou-Karistianis N; Stout JC
    Neurodegener Dis Manag; 2015; 5(2):155-64. PubMed ID: 25894879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical aggressive effect of propranolol in a patient with Huntington's disease.
    Stewart JT
    J Clin Psychiatry; 1987 Sep; 48(9):385-6. PubMed ID: 2957363
    [No Abstract]   [Full Text] [Related]  

  • 20. Social work with victims of Huntington's disease.
    Sands RG
    Soc Work Health Care; 1984; 9(4):63-71. PubMed ID: 6237442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.